Tag: Immuno
OSE Immuno: publication in Science Advances of data on CLEC-1, its new myeloid immune checkpoint
By Hector Chaunu Posted on 11/21/2022 at 8:46 p.m. Photo credit © ChaunuPictures …
OSE Immuno: new communications in sight
By Alexandra Saintpierre Published on 08/11/2022 at 7:12 p.m. (Boursier.com) —…
Ose immuno: Thanks to positive announcements for its cancer drug, OSE Immuno is soaring on the stock market
(BFM Bourse) – The Nantes biotechnology company announced Thursday evening that it had received compassionate access authorizations in three European countries for its potential therapeutic vaccine against non-small cell lung…
OSE Immuno: progress report on the cancer vaccine
(CercleFinance.com) – OSE Immunotherapeutics announces a progress report on Tedopi®, an immunotherapy for the activation of specific T lymphocytes against cancer cells, developed in advanced or metastatic non-small cell lung…
OSE Immuno: progress report on the cancer vaccine – 2022-10-20 at 18:18
(CercleFinance.com) – OSE Immunotherapeutics announces a progress report on Tedopi®, an immunotherapy for the activation of specific T lymphocytes against cancer cells, developed in advanced or metastatic non-small cell lung…
OSE Immuno presents the progress of its programs in Immuno-Oncology
By Claude Leguilloux Published on 10/12/2022 at 6:34 p.m. (Boursier.com) —…
Pharnext: recruits the legal director of OSE Immuno
(CercleFinance.com) – Pharnext announces today the appointment of Antoine Gravelle as Chief Legal Officer, effective July 1, 2022. A confirmed specialist in Law applied to the Health industries, Antoine Gravelle…
Ose Immuno: the title benefits from a broker analysis – 06/17/2022 at 16:47
(CercleFinance.com) – The Ose Immunotherapeutics share gained almost 6% in Paris, benefiting from a positive analysis by Invest Securities which maintained its buy opinion on the share and its price…
Ose Immuno: the title benefits from a broker analysis
(CercleFinance.com) – The Ose Immunotherapeutics share gained almost 6% in Paris, benefiting from a positive analysis by Invest Securities which maintained its buy opinion on the share and its price…
Ose immuno: Six experts join the scientific council
Read also (CercleFinance.com) – OSE Immunotherapeutics announces the appointment of six leading international experts to its new Scientific Board to support the Company in its new phase of growth and…
OSE Immuno: six experts join the scientific council
(CercleFinance.com) – OSE Immunotherapeutics announces the appointment of six leading international experts to its new Scientific Board to support the Company in its new phase of growth and its scientific…
Ose Immuno and Boehringer Ingelheim Announce First Patient Treated in Phase 1 Expansion Clinical Trial of BI 765063
By Claude Leguilloux Published on 05/03/2022 at 6:20 p.m. Photo credit © Reuters …